Pharmasset Inc. (VRUS) News

News for Pharmasset Inc. (VRUS)

Sector News | Topic News

Tue, Jan 17, 2012

5:00 PM

Gilead Sciences Completes Acquisition of Pharmasset, Inc. - Business Wire

Thu, Jan 12, 2012

1:25 AM

Gilead Sciences Completes Tender Offer for All Outstanding Shares of Pharmasset, Inc. - Business Wire

Mon, Dec 19, 2011

7:30 AM

Coronado Biosciences to Begin Trading on NASDAQ Today - Marketwire

Fri, Dec 16, 2011

8:00 AM

Pharmasset Announces Intent to Amend QUANTUM Trial - PR Newswire

Wed, Dec 07, 2011

9:00 AM

A Change in Tides - Featured Research on AutoZone, Inc. and Pharmasset, Inc. - Marketwire

Wed, Nov 30, 2011

10:00 PM

Bull & Lifshitz, LLP Announces Investigation of Pharmasset, Inc. - Business Wire

Tue, Nov 22, 2011

9:01 AM

Direction of Market Influences - Report Highlights BMC Software, Inc. and Pharmasset, Inc. - Marketwire

Mon, Nov 21, 2011

7:36 PM

Ryan & Maniskas, LLP Announces Investigation of Pharmasset, Inc. - Business Wire

7:06 PM

The Law Firm of Weiss & Lurie Investigates Pharmasset, Inc. - Business Wire

6:27 PM

Pomerantz Law Firm Investigates Claims on Behalf of Investors of Pharmasset, Inc. - Business Wire

3:39 PM

Pharmasset, Inc. Shareholder Alert: The Briscoe Law Firm and Powers Taylor, LLP Investigate the Board of Pharmasset, Inc. Concerning the Sale of Pharmasset to Gilead Sciences, Inc. - PR Newswire

2:54 PM

The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Pharmasset, Inc. in Connection with the Sale of the Company to Gilead Sciences, Inc. - PR Newswire

12:29 PM

Rigrodsky & Long, P.A. Announces Investigation of Pharmasset, Inc. - Business Wire

7:00 AM

Gilead Sciences to Acquire Pharmasset, Inc. for $11 Billion - Business Wire

Mon, Nov 14, 2011

5:11 PM

Pharmasset Reports Fiscal Year End 2011 Financial Results - PR Newswire

Sun, Nov 13, 2011

8:44 PM

Pharmasset to Present at the Lazard Capital Markets Healthcare Conference - PR Newswire

Tue, Nov 08, 2011

5:03 PM

Pharmasset to Present at Credit Suisse First Boston Healthcare Conference - PR Newswire

Fri, Nov 04, 2011

7:30 AM

Pharmasset to Webcast an Investor Event from the AASLD Meeting - PR Newswire

7:00 AM

New 12 Week, Interferon-Free Treatment Arms Added to All-Oral Combination Study of PSI-7977 and Daclatasvir (BMS-790052) for HCV Genotype 1 - PR Newswire

Tue, Nov 01, 2011

6:00 AM

Pharmasset Announces the Initiation of an Interferon-Free Phase 3 Program with PSI-7977 for HCV - PR Newswire

Mon, Oct 10, 2011

6:45 AM

Pharmasset Announces Further Expansion of ELECTRON Trial in Hepatitis C - PR Newswire

Wed, Sep 21, 2011

11:05 AM

Planned Clinical Trials at Dana-Farber/Harvard University Cancer Center a Big Deal for Little Cellceutix - Accesswire

Fri, Sep 16, 2011

4:45 PM

Pharmasset to Present at Two Upcoming Conferences - PR Newswire

Tue, Sep 13, 2011

6:45 AM

Pharmasset Initiates QUANTUM, a Phase 2b Interferon-Free Trial of PSI-7977 and PSI-938 for All HCV Genotypes - PR Newswire

Thu, Sep 08, 2011

9:00 AM

Global Situation & Resulting Influences - Research Report on Pharmasset, Inc. and InterMune, Inc. - Marketwire

First

1 2

Last